295 related articles for article (PubMed ID: 16708354)
21. Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA-87 and LALA-94 trials.
Tavernier E; Le QH; de Botton S; Dhédin N; Bulabois CE; Reman O; Vey N; Lhéritier V; Dombret H; Thomas X
Cancer; 2007 Dec; 110(12):2747-55. PubMed ID: 17963265
[TBL] [Abstract][Full Text] [Related]
22. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
Shah BK; Khanal A
Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
[TBL] [Abstract][Full Text] [Related]
23. Second malignancies in patients with Ewing Sarcoma Family of Tumors: A population-based study.
Sultan I; Rihani R; Hazin R; Rodriguez-Galindo C
Acta Oncol; 2010; 49(2):237-44. PubMed ID: 20100158
[TBL] [Abstract][Full Text] [Related]
24. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
Tadmor T; Liphshitz I; Silverman B; Polliack A
Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
[TBL] [Abstract][Full Text] [Related]
25. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia.
Brennan P; Coates M; Armstrong B; Colin D; Boffetta P
Br J Cancer; 2000 Apr; 82(7):1344-7. PubMed ID: 10755412
[TBL] [Abstract][Full Text] [Related]
26. The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment.
Enrici RM; Anselmo AP; Iacari V; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
Haematologica; 1998 Jul; 83(7):636-44. PubMed ID: 9718869
[TBL] [Abstract][Full Text] [Related]
27. Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was.
Sandin S; Hjalgrim H; Glimelius B; Rostgaard K; Pukkala E; Askling J
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1295-300. PubMed ID: 16835326
[TBL] [Abstract][Full Text] [Related]
28. Mortality among 5-year survivors of cancer diagnosed during childhood or adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Abanto ZU; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):460-7. PubMed ID: 16767717
[TBL] [Abstract][Full Text] [Related]
29. Salivary gland cancer in the United States.
Sun EC; Curtis R; Melbye M; Goedert JJ
Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1095-100. PubMed ID: 10613342
[TBL] [Abstract][Full Text] [Related]
30. Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study.
Mudie NY; Swerdlow AJ; Higgins CD; Smith P; Qiao Z; Hancock BW; Hoskin PJ; Linch DC
J Clin Oncol; 2006 Apr; 24(10):1568-74. PubMed ID: 16520465
[TBL] [Abstract][Full Text] [Related]
31. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD
J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468
[TBL] [Abstract][Full Text] [Related]
32. Mortality experiences among 15+ year survivors of childhood and adolescent cancers.
Lawless SC; Verma P; Green DM; Mahoney MC
Pediatr Blood Cancer; 2007 Mar; 48(3):333-8. PubMed ID: 16453299
[TBL] [Abstract][Full Text] [Related]
33. Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality.
Parsons MW; Rock C; Chipman JJ; Shah HR; Hu B; Stephens DM; Tao R; Tward JD; Gaffney DK
Cancer Med; 2023 Feb; 12(3):2624-2636. PubMed ID: 36812123
[TBL] [Abstract][Full Text] [Related]
34. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome.
Valesini G; Priori R; Bavoillot D; Osborn J; Danieli MG; Del Papa N; Gerli R; Pietrogrande M; Sabbadini MG; Silvestris F; Valsecchi L
J Rheumatol; 1997 Dec; 24(12):2376-80. PubMed ID: 9415645
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer risk factors and second primary malignancies among women with breast cancer.
Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
[TBL] [Abstract][Full Text] [Related]
36. Secondary non-Hodgkin lymphoma (NHL) in children and adolescents after childhood cancer other than NHL.
Landmann E; Oschlies I; Zimmermann M; Moser O; Graf N; Suttorp M; Greiner J; Reiter A;
Br J Haematol; 2008 Nov; 143(3):387-94. PubMed ID: 18729852
[TBL] [Abstract][Full Text] [Related]
37. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
[TBL] [Abstract][Full Text] [Related]
38. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias.
Monti G; Pioltelli P; Saccardo F; Campanini M; Candela M; Cavallero G; De Vita S; Ferri C; Mazzaro C; Migliaresi S; Ossi E; Pietrogrande M; Gabrielli A; Galli M; Invernizzi F
Arch Intern Med; 2005 Jan; 165(1):101-5. PubMed ID: 15642884
[TBL] [Abstract][Full Text] [Related]
39. Risk of second malignancies in long-term survivors of childhood cancer.
Cardous-Ubbink MC; Heinen RC; Bakker PJ; van den Berg H; Oldenburger F; Caron HN; Voûte PA; van Leeuwen FE
Eur J Cancer; 2007 Jan; 43(2):351-62. PubMed ID: 17141498
[TBL] [Abstract][Full Text] [Related]
40. Second primary ovarian cancer among women diagnosed previously with cancer.
Hall HI; Jamison P; Weir HK
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):995-9. PubMed ID: 11535553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]